Lower serum levels of anti‐inflammatory IL‐1RA, and chemokines IL‐8 and MCP‐1, and higher levels of anti‐inflammatory IL‐10, were detected at baseline prior to treatment in those patients who subsequently experienced urticaria (Figure 6C). This evidence concerns the gene CCL2 and urticaria.